| Company Name | Affinity Drug Design Limited |
|---|---|
| Company Status | Active |
| Company Number | 08466627 |
| Incorporation Date | 28 March 2013 (11 years, 1 month ago) |
| Dissolution Date | — |
| Category | Private Limited Company with Share Capital |
| Previous Names | — |
| Current Directors | Angela Finn and Paul William Finn |
| Business Industry | Human Health and Social Work Activities |
|---|---|
| Business Activity | Other Human Health Activities |
| Latest Accounts | 31 March 2023 (1 year ago) |
| Next Accounts Due | 31 December 2024 (8 months from now) |
| Accounts Category | Micro |
| Accounts Year End | 31 March |
| Latest Return | 28 March 2024 (1 month ago) |
| Next Return Due | 11 April 2025 (11 months, 2 weeks from now) |
| Registered Address | 6-7 Citibase, New Barclay House 234 Botley Road Oxford OX2 0HP |
|---|---|
| Shared Address | This company shares its address with over 100 other companies |
| Constituency | Oxford West and Abingdon |
|---|---|
| Region | South East |
| County | Oxfordshire |
| Built Up Area | Oxford |
| Accounts Year End | 31 March |
|---|---|
| Category | Micro |
| Latest Accounts | 31 March 2023 (1 year ago) |
| Next Accounts Due | 31 December 2024 (8 months from now) |
| Latest Return | 28 March 2024 (1 month ago) |
|---|---|
| Next Return Due | 11 April 2025 (11 months, 2 weeks from now) |
| SIC Industry | Human health and social work activities |
|---|---|
| SIC 2003 (8514) | Other human health activities |
| SIC 2007 (86900) | Other human health activities |
| 12 October 2020 | Micro company accounts made up to 31 March 2020 |
|---|---|
| 28 April 2020 | Confirmation statement made on 28 March 2020 with updates |
| 29 October 2019 | Change of share class name or designation |
| 11 September 2019 | Micro company accounts made up to 31 March 2019 |
| 5 April 2019 | Confirmation statement made on 28 March 2019 with no updates |
©2015-2024 Nexok Limited
All rights reserved
Registered in England and Wales #09741558
